December 18, 2025
1 min read

Bicycle gets radiopharmaceutical push from UK pact for reprocessed uranium

After seeing some of its financial momentum slow this year, Bicycle Therapeutics got a push from two U.K. nuclear agencies in the form of up to 440 tons of reprocessed uranium the biotech needs to develop lifesaving drugs.

Leave a Reply

Your email address will not be published.

Previous Story

STAT+: Employers drop coverage for weight loss drugs as pharma’s direct-to-consumer programs grow

Next Story

STAT+: Hospitals owned by real estate investors more likely to close or go bankrupt

Previous Story

STAT+: Employers drop coverage for weight loss drugs as pharma’s direct-to-consumer programs grow

Next Story

STAT+: Hospitals owned by real estate investors more likely to close or go bankrupt

Latest from Blog

Go toTop